US 10538763
Compounds and methods for modulation of DUX4
granted A61PA61P21/00
Quick answer
US patent 10538763 (Compounds and methods for modulation of DUX4) held by Ionis Pharmaceuticals, Inc. expires Mon Jan 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Jan 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61P, A61P21/00